“Medical decisions should not be made based on advertising. Consult a physician on the benefits and risks of particular hemp-derived products.”
Interest in creating therapeutic options that are made from either natural phytochemicals or synthetic cannabis derivatives has increased as knowledge of the endocannabinoid system has grown. A myriad of components makes up the endocannabinoid system, many of which are found in the majority of the body’s cell types.
The U.S. Food & Drug Administration (FDA) defines an active pharmaceutical ingredient (API) as any chemical or combination of substances intended to be employed as the active component in the production of a medicinal product. Such chemicals are designed to provide pharmacological action or other direct effects in the diagnosis, treatment, mitigation, or prevention of disease, as well as to alter the structure or function of the body. API can be found in the form of liquids, powders, crystals, and extracts that are produced through chemical synthesis, plant extraction, or biotechnology.
Clinical application of the product requires processing the API into a pharmaceutical formulation. A variety of raw materials with various physical and chemical properties are used in the synthesis of APIs, which is typically a challenging and multi-step process requiring several chemical transformations and operations. To perform API synthesis, specialized knowledge is required.
Difference Between Synthesis and Extraction
Depending on the company, the production of specific cannabis-based or cannabis-derived products and drugs and their specific strategies heavily influence whether chemical synthesis or extraction of phytochemicals is preferred. There are two or more stereoisomers of various cannabinoids. Despite having the same formula, these compounds’ atoms are arranged differently, which allows the molecules to have various pharmacological actions.
As a result, the extracted and synthesized products may have distinct chemical profiles due to the variations in the stereochemistry of plant-derived and synthetic forms of the same target cannabinoids. The strategy for producing various candidates may thus be determined by the desired end result.
Cannabis businesses can employ API synthesis to create cannabis products that are standardized, highly effective, and/or targeted. Abundant Labs is able to produce strains with consistent concentrations of different types of Cannabinoids and terpenes using a combination of stable plant genetics and automated, high-tech manufacturing procedures.
We believe that employing API production methods at Abundant Labs provides our customers with products that are not only of the absolute highest quality but also give us the ability to have complete control over the entire process. This practice helps us achieve our main goal, which is to provide consistent and safe products for our customers. Abundant Labs will continue to develop new means for providing high-quality products in a safe way to all consumers.
If you’re interested in learning about newer methods for obtaining CBD isolates and other products, take a look at our website and blog to learn more. And if you want to know more about Abundant Labs or the high-quality hemp products we make, don’t hesitate to reach out!